Emily Henders, 37, received her CAR T-cell therapy last week and hopes it will slow down or halt progression of her MS.

Patients suspecting they have multiple sclerosis (MS) are encountering significant delays in accessing specialist care, with ...

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the ...

Now, by analyzing thousands of proteins found in the blood, scientists at UC San Francisco have created the clearest picture ...

Subcutaneous ocrelizumab (SC OCR) maintains a safety profile similar to intravenous administration in multiple sclerosis patients. A 920 mg SC OCR dose was identified as optimal, with mild to moderate ...

The oral microbiome is home to more than 700 species of bacteria, and the average person hosts approximately 250 species at a time, according to the study. Each person’s oral microbiome is unique and ...

Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...

Patients with multiple sclerosis are more likely to form calcium phosphate stones and struvite stones. Kidney stone formers with multiple sclerosis (MS) are more likely than those without MS to form ...

UCSF study finds MS starts damaging the brain years before symptoms appear. Early immune attack on myelin and key proteins ...

Scientists have found that people with multiple sclerosis (MS) have a distinctly imbalanced oral microbiome—marked by a loss of beneficial bacteria and a rise in inflammation-linked microbes.

Researchers have traced the earliest stages of multiple sclerosis (MS), showing that the immune system begins attacking the brain up to seven years before diagnosis.

Jana Hlavacova, a Czech government employee who lives with MS, is helping shape policies in healthcare and the design of ...